HIMS & HERS HEALTH INC (HIMS) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
31.41 USD
+0.09 (+0.29%)
ChartMill assigns a Buy % Consensus number of 68% to HIMS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 46.4. This target is 47.71% above the current price.
- HIMS was analyzed by 21 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about HIMS.
- In the previous month the buy percentage consensus was at a similar level.
- HIMS was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-12 | Evercore ISI Group | Initiate | In-Line |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-04 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-04 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-10-21 | Keybanc | Initiate | Sector Weight |
| 2025-09-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-08-05 | Needham | Reiterate | Hold -> Hold |
| 2025-07-17 | Truist Securities | Maintains | Hold -> Hold |
| 2025-06-11 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-06-04 | Needham | Maintains | Buy -> Buy |
| 2025-05-06 | Needham | Reiterate | Buy -> Buy |
| 2025-05-06 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2025-05-06 | Citigroup | Maintains | Sell -> Sell |
| 2025-04-29 | TD Cowen | Downgrade | Buy -> Hold |
| 2025-04-29 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-04-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-25 | Citigroup | Maintains | Sell -> Sell |
| 2025-04-10 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-18 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-03-06 | B of A Securities | Reiterate | Underperform -> Underperform |
| 2025-03-06 | Citigroup | Reiterate | Sell -> Sell |
| 2025-02-26 | Truist Securities | Maintains | Hold -> Hold |
| 2025-02-25 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-02-25 | Needham | Maintains | Buy -> Buy |
| 2025-02-25 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-25 | Citigroup | Maintains | Sell -> Sell |
| 2025-02-20 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-02-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-18 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
HIMS & HERS HEALTH INC / HIMS FAQ
What is the price target for HIMS stock?
21 analysts have analysed HIMS and the average price target is 46.4 USD. This implies a price increase of 47.71% is expected in the next year compared to the current price of 31.41.
What is the consensus rating for HIMS & HERS HEALTH INC (HIMS) stock?
The consensus rating for HIMS & HERS HEALTH INC (HIMS) is 67.619 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for HIMS & HERS HEALTH INC stock?
The number of analysts covering HIMS & HERS HEALTH INC (HIMS) is 21.